S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Lixte BiotechnologyAzurRx BioPharmaNovaBay PharmaceuticalsAddex TherapeuticsNewron Pharmaceuticals
SymbolNASDAQ:LIXTNASDAQ:AZRXNYSEAMERICAN:NBYOTCMKTS:ADDXFOTCMKTS:NWPHF
Price Information
Current Price$4.48$1.50$1.10$1.65$2.44
52 Week RangeN/ABuyN/AN/AN/A
MarketRank™
Overall Score0.01.40.60.60.4
Analysis Score0.03.30.00.00.0
Community Score0.03.02.62.82.1
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.00.60.60.00.0
Analyst Ratings
Consensus RecommendationN/ABuyN/AN/AN/A
Consensus Price TargetN/A$3.25N/AN/AN/A
% Upside from Price TargetN/A116.67% upsideN/AN/AN/A
Trade Information
Market Cap$55.44 million$113.33 million$45.96 million$43.51 million$43.57 million
Beta-1.151.813.50.440.53
Average Volume1,498,19412,076,8747,203,097N/A4,170
Sales & Book Value
Annual RevenueN/AN/A$6.60 millionN/A$7.88 million
Price / SalesN/AN/A6.96N/A5.53
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book ValueN/A$0.17 per share$0.03 per shareN/A$2.31 per share
Price / BookN/AN/A36.67N/A1.06
Profitability
Net IncomeN/A$-15,180,000.00$-9,650,000.00N/A$-22,630,000.00
EPSN/AN/A($0.48)N/A($1.27)
Trailing P/E Ratio0.000.00N/A0.00N/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-122.78%N/AN/A
Return on Equity (ROE)N/A-316.41%-309.15%N/AN/A
Return on Assets (ROA)N/A-162.80%-93.80%N/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/A0.91%
Current RatioN/A4.40%5.33%N/A9.39%
Quick RatioN/A4.40%5.07%N/AN/A
Ownership Information
Institutional Ownership PercentageN/A5.14%2.69%N/A0.06%
Insider Ownership PercentageN/A7.30%1.80%N/AN/A
Miscellaneous
Employees110261926
Shares Outstanding12.37 million75.56 million41.78 million26.37 million17.85 million
Next Earnings DateN/AN/A3/25/2021 (Estimated)N/A3/4/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.